ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
665 hedge funds and large institutions have $22B invested in Alexion Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 100 funds opening new positions, 248 increasing their positions, 237 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 16 → 16 (0)
46% less call options, than puts
Call options by funds: $214M | Put options by funds: $394M
Holders
665
Holding in Top 10
16
Calls
$214M
Puts
$394M
Top Buyers
| 1 | +$103M | |
| 2 | +$95.3M | |
| 3 | +$95M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$82.5M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$80.7M |
Top Sellers
| 1 | -$530M | |
| 2 | -$203M | |
| 3 | -$168M | |
| 4 |
SSM
Sound Shore Management
Greenwich,
Connecticut
|
-$132M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$114M |